SD11 scFv for COVID-19

 SD11 scFv has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed SD11 scFv in detail.
Gu et al., Specific human antibodies against SARS-CoV-2 and monkeypox virus generated via a rapid construction and screening system, Immunobiology, doi:10.1016/j.imbio.2025.153124